FindTrial
Sign In

Evaluation of Tranexamic Acid in reducing blood loss during planned Caesarean birth

Evaluation of effectiveness of prophylactic parenteral Tranexamic Acid in reducing blood loss during elective lower segment caesarean section

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/04/041835
Enrollment
92
Registered
2022-04-12
Start date
Unknown
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: Z332- Encounter for elective terminationof pregnancy

Interventions

Intervention1: Parenteral administration of Tranexamic Acid: Inj. Tranexamic Acid 1 g mixed with 100 mL Normal Saline given intravenously 15 minutes before elective LSCS Control Intervention1: Parente

Sponsors

Esaivaani V
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Full term primigravida or multigravida with singleton pregnancy delivered by elective lower segment caesarean section

Exclusion criteria

Exclusion criteria: 1) Intake of anti-platelet agents, 2) History of thrombo-embolic disorder, 3) Pregnancy complications such as severe pre-eclampsia, abruptio placenta, placenta previa, fibroid complicating pregnancy, 4) Any blood dyscrasias, 5) Allergy to tranexamic acid, 6) Multiple pregnancy, 7) Polyhydramnios

Design outcomes

Primary

MeasureTime frame
Blood loss during caesarean sectionTimepoint: At the end of caesarean section—

Secondary

MeasureTime frame
Percentage difference in hemoglobin before and after LSCSTimepoint: 1 year—

Countries

India

Contacts

Public ContactEsaivaani V

Melmaruvathur Adhiparasakthi Institute of Medical Sciences and Research

esaiv1990@gmail.com9600536758

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026